Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Savills PLC Director's Dealing 2019

Apr 16, 2019

4850_dirs_2019-04-16_60d1ae4b-1408-47be-b046-2d04ebcbdcd7.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3783W

Savills PLC

16 April 2019

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS

Grant of Share Awards

The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under the Savills Deferred Share Bonus Plan to Directors and other persons discharging managerial responsibilities ('PDMR') as follows:-

Director/ PDMR Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR on

15 April 2019
Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan
Mark Ridley (Director) 39,673 134,119
Simon Shaw (Director) 59,182 158,540
Simon Hope (PDMR) 5,449 19,587
Chris Lee (PDMR) 12,643 37,008
Christian Mancini (PDMR) 9,940 26,403
James Sparrow (PDMR) 26,594 44,375

The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under The Schedule to The Savills Deferred Share Bonus Plan to PDMRs based in the United States of America as follows:-

PDMR Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the PDMR on

15 April 2019
Resulting beneficial interest under the Savills Deferred Share Bonus Plan
Mitchell Steir (PDMR) 17,190 34,588

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

The Company announces that on 15 April 2019 awards have been made under The Savills plc Performance Share Plan (the 'Performance Share Plan') to Directors and PDMRS as follows:- 

Director/ PDMR Number of shares subject to the Performance Share Plan awarded to the Director / PDMR on 15 April 2019 Total number of shares subject to Performance Share Plan Awards following this notification
Mark Ridley (Director) 62,997 161,579
Simon Shaw (Director) 48,174 149,835
Chris Lee (PDMR) 24,523 65,708

The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.

Awards of shares are made subject to a three-year performance period.  Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period for Directors.

Awards vest subject to the satisfaction of the following performance criteria measured over the three years following grant:

(a) 50% of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);

(b) the other 50% of the initial value of an award is subject to real (i.e. growth in excess of RPI) Group Earnings per Share ('EPS') growth performance.

Awards vest as follows:

(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points; and

(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's real EPS growth (i.e. growth in excess of RPI) is 3% p.a., compound rising to 100% (i.e. maximum) if the Company's real (i.e. growth in excess of RPI) EPS growth is 8% p.a., compound with sliding scale vesting between the two points.

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1. Details of the person discharging managerial responsibilities/ person closely associated
(a) Name 1.    Mark Ridley

2.    Simon Shaw

3.    Simon Hope

4.    Chris Lee

5.    Christian Mancini

6.    James Sparrow

7.    Mitchell Steir
2. Reason for the notification
(a) Position/ status 1.    Group Chief Executive/ Director

2.    Group Chief Financial Officer/ Director

3.    Global Head of Capital Markets/ PDMR

4.    Group Legal Director and Company Secretary/ PDMR

5.    Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR

6.    Chief Executive Officer UK & EMEA/ PDMR

7.    Chairman and CEO - Savills North America/ PDMR
(b) Initial notification/ Amendment Initial notification
3. Details of the issuer
(a) Name Savills plc
(b) LEI 213800WXICGMBWHTA933
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a) Description of the Financial Instrument Awards over Savills plc Ordinary Shares of 2.5p each
(b) Identification code of the Financial Instrument GB00B135BJ46
(c) Nature of the transaction Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP') and Performance Share Plan ('PSP')
(d) Price(s) and volume(s) Price(s) Volume(s)
£nil per share 1.    39,673 (DSBP) & 62,997 (PSP)

2.    59,182 (DSBP) & 48,174 (PSP)

3.    5,449 (DSBP)

4.    12,643 (DSBP) & 24,523 (PSP)

5.    9,940 (DSBP)

6.    26,594 (DSBP)

7.    17,190 (DSBP)
(e) Aggregated information

-      Aggregated volume

-      Price
N/A
(f) Date of the transaction 15 April 2019
(g) Place of the transaction Outside a trading venue

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

16 April 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHKMGMDMVMGLZM